Ying Chen

Ying Chen has extensive work experience in the pharmaceutical industry. They started their career as a Research Assistant at the University of Minnesota in 2003 and worked in this role until 2008. After that, they joined Pfizer Pharmaceuticals as a Sr. Scientist from December 2008 to May 2010.

In 2011, Ying Chen worked as a Consultant in Clinical Pharmacology at ImClone Systems, a subsidiary of Eli Lilly and Company, until August 2012. Following this, they joined Prinston Pharmaceutical Inc. as a Sr. Scientist from August 2012 to December 2014.

Ying Chen then progressed through various roles in Scientific Affairs at Prinston Pharmaceutical Inc. They served as a Manager from January 2015 to August 2017, an Associate Director from September 2017 to December 2019, and finally as the Director from January 2020 to December 2021.

Currently, Ying Chen is working at KBP Biosciences as the Sr. Director of Project Management, starting from January 2022.

Ying Chen completed their education in pharmaceutical science with an MS degree at China Pharmaceutical University from 1999 to 2002. Following this, they pursued further studies at the University of Minnesota from 2003 to 2008, obtaining a PhD degree in pharmaceutics.